Published in:
Open Access
01-12-2011 | Poster presentation
Interleukin-1 antagonists in Mevalonate Kinase Deficiency
Authors:
C Galeotti, L Rossi-Semerano, S Guillaume, A Duquesne, P Pillet, O Richer, E Hachulla, I Koné-Paut
Published in:
Pediatric Rheumatology
|
Special Issue 1/2011
Login to get access
Excerpt
Mevalonate Kinase Deficiency (MKD) is one of the autoinflammatory fever syndromes, caused by mutations in the MKD gene. Systemic inflammatory symptoms may be mild to severe leading to early death, and recurrent bacterial infections frequently develop in the disease course. On demand NSAID and steroids are the most commonly used. Few case-reports suggested that interleukin-1 (IL-1) antagonists could alleviate MKD symptoms. …